Supplier · public contract awards
Hikma Pharma GmbH public contracts.
Hikma Pharma GmbH has won 129 public contracts between 2018 and 2026 from 18 public buyers in 2 countries. Its most frequent buyer is IKK classic (22 awards). Besides Germany, it has won contracts in Austria. Outside TED, published values total €7.82 million across 8 awards. 67 awards were published on TED; the median contract size is about €94,000 (2 contracts with a value).
129Contracts won
18Public buyers
2Countries
Mar 2026Latest award
Latest contracts won
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026Awarded by Pbmg Eg · Germany
3 Mar 2026Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025Awarded by Pbmg Eg · Germany
15 Apr 2025Awarded
Németország – Gyógyszerészeti termékek – Q/E2DT/R8451_79 - 79. EA DBS AM - Ceftriaxondinatrium zur InjektionAwarded by Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr · Germany
11 Mar 2025Awarded
Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Hydroxycarbamid (L01XX05) im RahmeAwarded by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Germany
12 Jan 2024Awarded
Lieferung parenterale Antibiotika 2023/2024Awarded by Tirol Kliniken GmbH · Austria
24 Nov 2023Awarded
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Colistin bzw. Colistimethat natrium (ATC-Awarded by GWQ ServicePlus AG · Germany
1 Aug 2023Awarded
Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (L02AE02, H01CA04) im Awarded by AOK - Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Germany
9 Jun 2023Awarded
Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (L02BA03) im Rahmen eiAwarded by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Germany
9 May 2023Awarded
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff MeropenemAwarded by GWQ ServicePlus AG · Germany
1 Feb 2023Awarded
Abschluss von Arzneimittelrabattverträgen im Sinne des § 130a Abs. 8 SGB V 2019-2Awarded by Deutsche Rentenversicherung Knappschaft-Bahn-See · Germany
16 Jun 2020Awarded
Contracts won by year
Contracts won by year
from the published records20182
20192
20202
202312
20242
20253
20262
Published value, by currency (feeds other than TED)
EUR · 8 valued
€7.82 million
Typical contract size on TED
EUR · median of 2 contracts
€94,000
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against Hikma Pharma GmbH?
askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
Start bidding ↗ See open tenders